Found: 21
Select item for more details and to access through your institution.
P1‐092: PBD‐C06 – A NOVEL ANTI‐PGLU3‐Aβ ANTIBODY FOR IMMUNOTHERAPY AGAINST ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P270, doi. 10.1016/j.jalz.2019.06.647
- By:
- Publication type:
- Article
A Fusion Inhibitor (FP-21399) for the Treatment of Human Immunodeficiency Virus Infection: A Phase I Study.
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 2, doi. 10.1086/315703
- By:
- Publication type:
- Article
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1647, doi. 10.1007/s00262-018-2223-z
- By:
- Publication type:
- Article
Intratumoral immunocytokine treatment results in enhanced antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1891, doi. 10.1007/s00262-008-0519-0
- By:
- Publication type:
- Article
Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1765, doi. 10.1007/s00262-007-0320-5
- By:
- Publication type:
- Article
huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 447, doi. 10.1007/s00262-006-0203-1
- By:
- Publication type:
- Article
NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 1, p. 41, doi. 10.1007/s00262-003-0435-2
- By:
- Publication type:
- Article
Immunocytokines: amplification of anti-cancer immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 5, p. 297, doi. 10.1007/s00262-002-0349-4
- By:
- Publication type:
- Article
Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 8, p. 449, doi. 10.1007/s00262-002-0302-6
- By:
- Publication type:
- Article
Cell type-specific enhancer element associated with a mouse MHC gene, E<sub>β</sub>.
- Published in:
- Nature, 1984, v. 310, n. 5978, p. 594, doi. 10.1038/310594a0
- By:
- Publication type:
- Article
Effect of Antiangiogenic Theraphy on Slowly Growing, Poorly Vascularized Tumors in Mice.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 5, p. 382
- By:
- Publication type:
- Article
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01610
- By:
- Publication type:
- Article
Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer's disease with reduced complement activation.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60319-5
- By:
- Publication type:
- Article
Current and Potential Uses of Immunocytokines as Cancer Immunotherapy.
- Published in:
- Antibodies (2073-4468), 2012, v. 1, n. 2, p. 149, doi. 10.3390/antib1020149
- By:
- Publication type:
- Article
NK cells engineered to express a GD<sub>2</sub>-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 3, p. 569, doi. 10.1111/j.1582-4934.2011.01343.x
- By:
- Publication type:
- Article
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma.
- Published in:
- Theranostics, 2022, v. 12, n. 13, p. 5615, doi. 10.7150/thno.56736
- By:
- Publication type:
- Article
Antibody-interleukin 2 fusion proteins: A new approach to cancer therapy.
- Published in:
- Journal of Clinical Laboratory Analysis, 1996, v. 10, n. 3, p. 160, doi. 10.1002/(SICI)1098-2825(1996)10:3<160::AID-JCLA9>3.0.CO;2-F
- By:
- Publication type:
- Article
A new platform for constructing antibody-cytokine fusion proteins (immunocytokines) with improved biological properties and adaptable cytokine activity.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2013, v. 26, n. 10, p. 561, doi. 10.1093/protein/gzt045
- By:
- Publication type:
- Article
Improvement of Fcerythropoietin structure and pharmacokinetics by modification at a disulfide bond.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2005, v. 18, n. 3, p. 111, doi. 10.1093/protein/gzi021
- By:
- Publication type:
- Article
Engineering a pharmacologically superior form of leptin for the treatment of obesity.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2005, v. 18, n. 1, p. 1
- By:
- Publication type:
- Article